Citrullimycines, a process for their production and their use as pharmaceuticals
Details for Australian Patent Application No. 2002223566 (hide)
International Classifications
Event Publications
15 December 2005 Assignment before Grant
Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH
22 December 2005 Application Accepted
Published as AU-B-2002223566
27 April 2006 Standard Patent Sealed
23 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser